Confirm Inactivation Of Xmrv By The Intercept
Inviato 18 maggio 2010 - 18:34:53
INTERCEPT Blood System
- Virus linked to chronic fatigue syndrome and prostate cancer is viewed as a blood transfusion risk –
CONCORD, California and RENO, Nevada--(BUSINESS WIRE)— May 18, 2010-- The
Whittemore Peterson Institute for Neuro-Immune Disease (WPI) and Cerus Corporation
(NASDAQ:CERS) announced positive results from a study demonstrating the efficacy of the
INTERCEPT Blood System to inactivate XMRV, a human retrovirus, in donated platelet components. After sample platelet components were inoculated with XMRV, the infected blood components were treated with INTERCEPT, a system that inactivates pathogens in donated blood. Following treatment, no evidence of infectious XMRV was detected in blood samples.
The study results have been submitted for presentation at the AABB Annual Meeting in October.
XMRV is a retrovirus that has recently been linked to prostate cancer and myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS). Other retroviruses, such as HIV and
HTLV-1, are known to cause cancer and immune deficiencies. Studies by WPI researchers and
collaborators have confirmed that infectious XMRV can be found in human blood cells and that
the virus is transmitted through body fluids.
Read more document on pdf format: www.wpinstitute.org/news/news_current.html
"In medicina tutto quello che è sconosciuto è malattia mentale" (...)
"Una delle malattie più diffuse è la diagnosi." (Karl Kraus)
Le foto di Zac qui: PhotoZac
0 utente(i) stanno leggendo questa discussione
0 utenti, 0 ospiti, 0 utenti anonimi